Professor Yan Shuxun′s experience in treating thyroid cancer postoperatively from the liver
HAN Qingqing1 WANG Ying2 DUAN Fei1 WANG Zejin3 GUO Panpan1 YAN Miaomiao4 CHEN Yalin1 YAN Zhao1 YAN Shuxun1,5
1.Ward 2, Department of Endocriology, the First Affiliated Hospital of He′nan University of Chinese Medicine, He′nan Province, Zhengzhou 450000, China; 2.Department of Geriatric Cardiology, the First Affiliated Hospital of Zhengzhou University, He′nan Province, Zhengzhou 450000, China;
3.Medical College, Hebei University of Engineering, Hebei Province, Handan 056038, China;
4.College of Acupuncture and Massage, He′nan University of Chinese Medicine, He′nan Province, Zhengzhou 450046, China;
5.He′nan Workstation, Inheritance Studio of Chen′s Goiter Academic School in Hubei, State Administration of Traditional Chinese Medicine, He′nan Province, Zhengzhou 450000, China
Abstract:Thyroid cancer (TC) is a common malignancy tumor of the endocrine system. Professor Yan Shuxun believes that thyroid diseases, including TC and postoperative TC diseases, are closely related to the liver, whether they are from the meridian circulation or physiological and pathological changes. Professor Yan believes that the common causes of postoperative TC include seven-pathogenic diseases, surgical trauma, iodine and thyroid hormones. He also attaches importance to the differences in the emotional factors of liver qi, liver fire, and liver yang in the process of disease evolution, and proposes that stagnation of liver qi, exuberance of liver fire, and upper hyperactivity of liver yang are the main pathogenesis of early patients in TC and postoperative TC. This article analyzes the disease by summarizing Professor Yan Shuxun′s experience in the treatment of TC from the treatment of liver diseases and combined with Chinese medicine.
韩青青1 王颖2 段飞1 王泽瑾3 郭盼盼1 燕苗苗4 陈亚琳1 闫诏1 燕树勋1,5. 燕树勋教授从肝论治甲状腺癌术后疾病经验总结[J]. 中国医药导报, 2019, 16(25): 138-141.
HAN Qingqing1 WANG Ying2 DUAN Fei1 WANG Zejin3 GUO Panpan1 YAN Miaomiao4 CHEN Yalin1 YAN Zhao1 YAN Shuxun1,5. Professor Yan Shuxun′s experience in treating thyroid cancer postoperatively from the liver. 中国医药导报, 2019, 16(25): 138-141.